IP Verse

Boehringer Ingelheim Pharma Gmbh & Co. Kg competitive analysis

Latest oppositions filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg

Explore patent oppositions filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3219328
Human Anti-Il-23 Antibodies, Compositions, Method And UsesJANSSEN BIOTECHMar 17, 2021
EP2634243
Improved Process For The Culturing Of CellsDPXJun 5, 2018
EP2634242
Improved Process For The Culturing Of CellsDPXJan 4, 2018
EP2634250
Improved Process For The Culturing Of CellsDPXJan 4, 2018

Latest patents of Boehringer Ingelheim Pharma Gmbh & Co. Kg opposed by its competitors

Explore Boehringer Ingelheim Pharma Gmbh & Co. Kg's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2152341
Apr 2, 2025Atomizer, And Filter2
EP2397142
Jul 27, 2022Use Of Dpp Iv Inhibitors5
EP2433665
Aug 7, 2019Inhaler And Sieve For An Inhaler1
EP1940349
Feb 14, 2018Aerosol Formulation For The Inhalation Of Beta Agonists2
EP1830843
Nov 7, 2012Indolidone Derivatives For The Treatment Or Prevention Of Fibrotic Diseases1

Latest PTAB cases involving Boehringer Ingelheim Pharma Gmbh & Co. Kg

Discover the latest PTAB cases involving Boehringer Ingelheim Pharma Gmbh & Co. Kg, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim Pharma Gmbh & Co. Kg with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BOEHRINGER INGELHEIM3318789
DPX - 12 - -
DSM ASSETS22116 - 15
PATHEON I - 12 - -